122 related articles for article (PubMed ID: 36740958)
1. Prognostic effects of previous cancer history on patients with major salivary gland cancer.
Li J; Rao Y; Wang X; Yu L; Qiu K; Mao M; Song Y; Pang W; Cheng D; Zhang Y; Feng L; Wang X; Shao X; Luo Y; Zheng Y; Li X; Xu Y; Xu W; Zhao Y; Ren J
Oral Dis; 2024 Mar; 30(2):492-503. PubMed ID: 36740958
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy.
Liu G; Zheng H; Zhang Z; Wu Z; Xiong H; Li J; Song L
BMC Cancer; 2010 Sep; 10():495. PubMed ID: 20846391
[TBL] [Abstract][Full Text] [Related]
3. Contemporary treatment patterns and outcomes of salivary gland carcinoma: a National Cancer Database review.
Ferrell JK; Mace JC; Clayburgh D
Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):1135-1146. PubMed ID: 30649610
[TBL] [Abstract][Full Text] [Related]
4. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of Nomograms to Predict Risk and Prognosis in Salivary Gland Carcinoma Patient with Distant Metastases.
Shi J; Fan Y; Long J; Zhang S; Zhang Z; Tang J; Chen W; Liu S
Ear Nose Throat J; 2023 Dec; ():1455613231212060. PubMed ID: 38044557
[No Abstract] [Full Text] [Related]
6. Survival Outcome of Intermediate-Grade Salivary Gland Carcinoma.
Park GC; Roh JL; Cho KJ; Jung YG; Lee HW; Kim TG; Choi SH; Nam SY; Kim SY
Oncology; 2018; 94(2):125-132. PubMed ID: 29151106
[TBL] [Abstract][Full Text] [Related]
7. Risk of breast cancer in women after a salivary gland carcinoma or pleomorphic adenoma in the Netherlands.
Valstar MH; Schaapveld M; van den Broek EC; van Velthuysen MF; de Ridder M; Schmidt MK; van Dijk BAC; Balm AJM; Smeele LE
Cancer Med; 2021 Jan; 10(1):424-434. PubMed ID: 33247629
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous impact of smoking on major salivary gland cancer according to histopathological subtype: A case-control study.
Sawabe M; Ito H; Takahara T; Oze I; Kawakita D; Yatabe Y; Hasegawa Y; Murakami S; Matsuo K
Cancer; 2018 Jan; 124(1):118-124. PubMed ID: 28881386
[TBL] [Abstract][Full Text] [Related]
9. Nomogram-Based Prediction of Overall and Disease-Specific Survival in Patients With Postoperative Major Salivary Gland Squamous Cell Carcinoma.
Li L; Zhang D; Ma F
Technol Cancer Res Treat; 2022; 21():15330338221117405. PubMed ID: 35950233
[No Abstract] [Full Text] [Related]
10. Prognostic factors and treatment considerations of submandibular gland carcinomas: A population-based study.
Liu S; Xu W; Liu L; Zhu Y; Wu Y; Lu H; Yang W; Zhang C
Oral Dis; 2023 Nov; 29(8):3298-3305. PubMed ID: 35821655
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Tumor Heterogeneity and SUVmax of Pretreatment 18F-FDG PET/CT for Salivary Gland Carcinoma With High-Risk Histology.
Cheng NM; Hsieh CE; Liao CT; Ng SH; Wang HM; Fang YD; Chou WC; Lin CY; Yen TC
Clin Nucl Med; 2019 May; 44(5):351-358. PubMed ID: 30932974
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a clinical prediction-score model for distant metastases in major salivary gland carcinoma.
Lukovic J; Alfaraj FA; Mierzwa ML; Marta GN; Xu W; Su J; Moraes FY; Huang SH; Bratman SV; O'Sullivan B; Kim JJ; Ringash JG; Waldron J; de Almeida JR; Goldstein DP; Casper KA; Rosko AJ; Spector ME; Kowalski LP; Hope A; Hosni A
Ann Oncol; 2020 Feb; 31(2):295-301. PubMed ID: 31959347
[TBL] [Abstract][Full Text] [Related]
13. Head & neck acinar cell carcinoma: a population-based study using the seer registry.
Yibulayin F; Feng L; Wang M; Lu MM; Luo Y; Liu H; Yang ZC; Wushou A
BMC Cancer; 2020 Jul; 20(1):631. PubMed ID: 32641007
[TBL] [Abstract][Full Text] [Related]
14. Astrocyte elevated gene-1 (AEG-1) is a marker for aggressive salivary gland carcinoma.
Liao WT; Guo L; Zhong Y; Wu YH; Li J; Song LB
J Transl Med; 2011 Dec; 9():205. PubMed ID: 22133054
[TBL] [Abstract][Full Text] [Related]
15. Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma-Specific Prognostic Relevance.
Siqueira JM; Mitani Y; Hoff CO; Bonini F; Guimaraes de Sousa L; Marques-Piubelli ML; Purushothaman A; Mitani M; Dai H; Lin SY; Spiotto MT; Hanna EY; McGrail DJ; El-Naggar AK; Ferrarotto R
Mod Pathol; 2024 Jan; 37(1):100371. PubMed ID: 38015043
[TBL] [Abstract][Full Text] [Related]
16. A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer.
Rodriguez CP; Wu QV; Voutsinas J; Fromm JR; Jiang X; Pillarisetty VG; Lee SM; Santana-Davila R; Goulart B; Baik CS; Chow LQM; Eaton K; Martins R
Clin Cancer Res; 2020 Feb; 26(4):837-845. PubMed ID: 31796519
[TBL] [Abstract][Full Text] [Related]
17. Salivary gland carcinoma (SGC) with perineural spread and/or positive resection margin - high locoregional control rates after photon (chemo) radiotherapy - experience from a monocentric analysis.
Haderlein M; Scherl C; Semrau S; Lettmaier S; Hecht M; Putz F; Iro H; Agaimy A; Fietkau R
Radiat Oncol; 2019 Apr; 14(1):68. PubMed ID: 31014362
[TBL] [Abstract][Full Text] [Related]
18. Second cancer incidence and risk factors in patients with salivary gland cancers.
Kwon M; Lee JI; Roh JL; Cho KJ; Choe J; Choi SH; Nam SY; Kim SY
JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):118-23. PubMed ID: 24370632
[TBL] [Abstract][Full Text] [Related]
19. Stromal collagen type VI associates with features of malignancy and predicts poor prognosis in salivary gland cancer.
Angenendt L; Mikesch JH; Görlich D; Busch A; Arnhold I; Rudack C; Hartmann W; Wardelmann E; Berdel WE; Stenner M; Schliemann C; Grünewald I
Cell Oncol (Dordr); 2018 Oct; 41(5):517-525. PubMed ID: 29949051
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
Kim Y; Lee SJ; Lee JY; Lee SH; Sun JM; Park K; An HJ; Cho JY; Kang EJ; Lee HY; Kim J; Keam B; Kim HR; Lee KE; Choi MY; Lee KH; Ahn MJ
Cancer; 2017 Jun; 123(11):1958-1964. PubMed ID: 28102887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
